FDA's strengthened global inspection program helps ensure generic drug safety

17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines.  ...

Read more →

Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death

10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...

Read more →

Allegations of widespread fraud raise questions about the safety of generic drugs made overseas

10 May 2019 - It is something we've all heard before: generic drugs are the same as brand-name drugs. They ...

Read more →

Working together for safe medicines in the EU

6 May 2019 - EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines ...

Read more →

When prescribing cures for 'overpriced' drugs, Government's first duty is do no harm

25 April 2019 - Overpriced. Excessive. Escalating. Gouging.  ...

Read more →

Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing

12 April 2019 - EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of ...

Read more →

New EudraVigilance system improves reporting of side effects and detection of safety signals

27 March 2019 - The new and improved EudraVigilance, the European system for managing and analysing information on suspected adverse ...

Read more →

Many local governments shrug off FDA warning about Canadian drug imports

7 March 2019 - Cities and local governments in several states said they will continue to use a Canadian company ...

Read more →

Statement from FDA Commissioner on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic

12 February 2019 - The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA.  ...

Read more →

Fake drugs could put patients at risk after no-deal Brexit

8 February 2019 - Patients could be put at risk from fake medicines if the UK exits the EU without ...

Read more →

New safety features for medicines sold in the EU

8 February 2019 - As of 9 February 2019, most prescription medicines and some over-the-counter medicines for human use supplied ...

Read more →

FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines

7 February 2019 - A key element of the U.S. FDA’s mission is focused on helping to ensure that all ...

Read more →

Risk classification of antimicrobials used in animals opens for public consultation

5 February 2019 - EMA has published today for public consultation its updated scientific advice on the categorisation of antimicrobials.  ...

Read more →

FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications

24 January 2019 - In making decisions about whether the benefits of a drug outweighs its risks, there are many ...

Read more →

FDA issues letter about paclitaxel coated balloons and eluting stents

17 January 2019 - Today the FDA issued a letter to health care providers about a recent publication in the Journal ...

Read more →